Disease | myocardial infarction |
Symptom | C0796095|c syndrome |
Sentences | 21 |
PubMedID- 23411742 | We conclude that prevalence of metabolic syndrome in patients with premature myocardial infarction is high; high tg is the most common component of metabolic syndrome. |
PubMedID- 20488312 | Metabolic syndrome and risk of acute myocardial infarction a case-control study of 26,903 subjects from 52 countries. |
PubMedID- 25789257 | This finding might partly explain the higher risk of development of heart failure following acute myocardial infarction in patients with metabolic syndrome. |
PubMedID- 24020829 | Intra-thoracic fat volume is associated with myocardial infarction in patients with metabolic syndrome. |
PubMedID- 20811489 | We sought to determine and compare the prevalence of the metabolic syndrome (ms) in patients with acute myocardial infarction (ami) utilizing the new international diabetes federation (idf) definition with the older national cholesterol education program (ncep) definition. |
PubMedID- 21159478 | Acute inferior myocardial infarction with nephrotic syndrome. |
PubMedID- 21646744 | Heart failure mimicking prior myocardial infarction in a patient with idiopathic hypereosinophilic syndrome. |
PubMedID- 23635324 | In the cardiovascular inflammation reduction trial (cirt) low dose methotrexate (target dose 20 mg/week) is tested for reduction of major cvd events among post-myocardial infarction patients with diabetes or metabolic syndrome. |
PubMedID- 22701134 | Clinical impact of non-high density lipoprotein-cholesterol and apolipoprotein b on clinical outcomes in metabolic syndrome patients with acute myocardial infarction undergoing percutaneous coronary intervention. |
PubMedID- 25563711 | Conclusions: this prospective observational cohort trial demonstrated that chronic ace-i therapy was an independent predictor for reduced periprocedural myocardial infarction among patients with metabolic syndrome who underwent elective coronary intervention. |
PubMedID- 21757819 | Background: the purpose of the present study was to compare the efficacy and safety of paclitaxel-eluting stent (pes), sirolimus-eluting stent (ses), and zotarolimus-eluting stent (zes) in primary percutaneous coronary intervention (pci) for acute st-segment elevation myocardial infarction (stemi) with metabolic syndrome (ms). |
PubMedID- 23715346 | The study was aimed to find out the impact of metabolic syndrome in patients with acute myocardial infarction during hospital stay. |
PubMedID- 21428179 | Conclusion: elevated homocysteine levels were correlated to the metabolic syndrome in patients with prior myocardial infarction. |
PubMedID- 22240598 | Coronary artery bypass grafting for multivessel coronary artery disease in metabolic syndrome patients with acute myocardial infarction. |
PubMedID- 21129152 | It also reduced the risk of myocardial infarction in patients with severe metabolic syndrome by 56% (8 year follow-up) and the development of type 2 diabetes by almost half (2 and 5 year follow-up) . |
PubMedID- 20509277 | Aim: to analyze the components of metabolic syndrome from patients with cardiovascular disease (myocardial infarction). |
PubMedID- 19356813 | Obesity and the metabolic syndrome in patients with acute myocardial infarction. |
PubMedID- 22263382 | Metabolic syndrome and outcome in patients with acute myocardial infarction. |
PubMedID- 22971940 | Presence of metabolic syndrome is associated with larger myocardial infarction size and complications following acute myocardial infarction. |
PubMedID- 23934969 | Objective: this study aimed to evaluate long-term survival according to the presence of metabolic syndrome (ms) in patients with acute myocardial infarction (ami) undergoing successful percutaneous coronary intervention (pci) with drug-eluting stents (des). |
PubMedID- 20890426 | We sought to determine the prevalence of metabolic syndrome (ms) in patients with acute myocardial infarction and its effect on clinical outcomes. |
Page: 1